Puma Biotechnology (PBYI) Operating Income (2010 - 2026)
Puma Biotechnology (PBYI) posted Operating Income of $7.59 million for Q2 2026, up 14.3% from $6.64 million a year earlier.
Powered by 
Analysis
Puma Biotechnology (PBYI) Operating Income (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at Puma Biotechnology was $30.44 million, down 33.9% year-over-year; for FY2025, it was $37.3 million, up 20.5% from FY2024.
- In prior years, Puma Biotechnology's Operating Income was $30.97 million in FY2024 (-5.1%), $32.64 million in FY2023 (+37.6%), $23.72 million in FY2022 and $1.29 million in FY2021.
- Quarterly Operating Income has run from a low of -$8.95 million in Q3 2021 to a high of $22.08 million in Q3 2024 over five years.
- On a year-over-year basis, Operating Income increased in three of the last five quarters, with growth averaging 26.6%.
- The strongest year-over-year quarter for Operating Income in the past five years was Q3 2023, with growth of 258.8%; the weakest was Q2 2023, with a decline of 59.4%.
- According to Business Quant data, Operating Income for the three prior quarters was -$3.83 million (Q1 2026), $17.11 million (Q4 2025) and $9.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Puma Biotechnology | 420.82 Mn | 19.27 Mn | 39.86 Mn | 5.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.27 Mn |
| Jun 30, 2026 | 7.59 Mn |
| Mar 31, 2026 | -3.83 Mn |
| Dec 31, 2025 | 17.11 Mn |
| Sep 30, 2025 | 9.57 Mn |
| Jun 30, 2025 | 6.64 Mn |
| Mar 31, 2025 | 3.98 Mn |
| Dec 31, 2024 | 13.37 Mn |
| Sep 30, 2024 | 22.08 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Sep 30, 2023 | 8.59 Mn |
| Jun 30, 2023 | 4.89 Mn |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 2.39 Mn |
| Jun 30, 2022 | 12.06 Mn |
| Mar 31, 2022 | -747,000.00 |
| Dec 31, 2021 | 6.83 Mn |
API Access
Puma Biotechnology Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();